Latest News - Humana
Top Corporates Hub
Humana
Humana (OM:HUM) Q3 Results Confront A Persistent Margin Squeeze
23.10.2026 14:17
Humana just posted its Q3 2026 scorecard and the headline is simple. Profit swung back to a solid quarter with basic earnings per share of 2.59 SEK on revenue of 2,595 million SEK. The share price, sitting at SEK70.40 into the release with a 7‑day return effectively flat, reflected a market still unsure about the story. The real tension is psychological. Traders are reacting to a healthcare operator that now earns a trailing P/E of 18.8x while carrying a thin 1.8% net margin and a history of...
How Clinic JV Funding At Humana (HUM) Has Changed Its Investment Story
21.10.2026 05:15
Humana announced a joint venture with HPS Investment Partners, part of BlackRock, to manage nearly 150 CenterWell Senior Primary Care clinics, with BlackRock acquiring WCAS’s equity stake valued at about US$2.8b and Humana expecting reduced balance sheet liabilities. The structure keeps CenterWell running the clinics while bringing in fresh capital for new locations and acquisitions. This directly affects Humana’s capital intensity, funding sources, and long term optionality to buy back the...
Humana (HUM) Recasts CenterWell Clinics With New Joint Venture And Fresh Capital
21.10.2026 04:29
Humana (NYSE:HUM) has formed a new joint venture with BlackRock's HPS Investment Partners to operate CenterWell senior primary care clinics. The HPS Investment Partners vehicle becomes the new majority owner of the CenterWell clinics platform, replacing Humana's prior partner Welsh, Carson, Anderson & Stowe. The refreshed structure is intended to fund CenterWell clinic expansions and acquisitions while removing earlier put arrangements that sat on Humana's balance sheet. Humana's new...
AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife® IRE for Prostate and Liver Cancer
14.10.2026 11:00
LATHAM, N.Y., October 14, 2026--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Humana has updated its Medicare Advantage coverage policy to apply Local Coverage Determination (LCD) L40205 medical necessity criteria for irreversible electroporation (IRE), the non-thermal ablation tec
Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
13.10.2026 10:22
LOUISVILLE, Ky., October 13, 2026--Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock ("BlackRock"), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will re
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
13.10.2026 10:00
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs, GPOs and Cancer CentersTAMPA, FL / ACCESS Newswire / October 13, 2026 / DataMeds AI, Inc. ChemoFx has recently been included, for the first time, in a Humana Medicaid coverage policy for gynecologic cancers.
UNH Stock Rises Overnight Ahead Of Earnings: Analyst Outlines ‘Short Premium’ Play To Cut January Call Cost By Nearly 60%
13.10.2026 06:09
Tidal Financial Group strategist Michael Khouw says options imply a 6.5% earnings move, with implied volatility at 40%, twice the stock’s realized volatility.
Humana leads Managed Care winners in new CMS Star Ratings - Evercore
12.10.2026 19:45
Investing.com -- Managed care insurers face divergent earnings impacts from the Centers for Medicare and Medicaid Services' 2027 Star Ratings, with Humana positioned for significant upside while UnitedHealth confronts the largest headwind, according to an Evercore note to clients from analyst Elizabeth Anderson following the CMS release.
Humana (HUM) Gets a Major Ratings Boost. Can Earnings Justify the Valuation?
12.10.2026 18:39
On October 9, Humana Inc. (NYSE:HUM) gained more than 11% after analysts named it the biggest potential beneficiary of the new Medicare Advantage star ratings for 2027. Earlier this year, the stock also ranked 5th on our list of the 7 Best Turnaround Stocks to Buy in 2026. See which four stocks ranked higher than […]
Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?
12.10.2026 17:12
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
12.10.2026 14:48
DataMeds AI’s Helomics subsidiary has received a Medicaid coverage determination under Humana’s policy, potentially expanding reimbursement access for its precision oncology test while supporting commercial growth. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) has secured a Medicaid coverage determination for its ChemoFx Assay through subsidiary Helomics Corporation.
Humana Hits 95% Four-Star Coverage: What it Means for HUM
12.10.2026 14:21
Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
12.10.2026 10:00
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policyTAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. Medical Coverage Policies were reviewed by Humana's Medicaid Coverage Policy Adoption (MCPA) Forum, which incorporated the ChemoFx Assay in its Coverage Determination for Pharmacogenomics Testing[1].
Raymond James Upgrades Humana to Outperform, Announces $520 Price Target
12.10.2026 07:25
Raymond James analyst John Ransom upgrades Humana (NYSE:HUM) from Market Perform to Outperform and announces $520 price target.
Dow Jumps Over 400 Points, Records Weekly Gain: Investor Sentiment Improves, Fear & Greed Index Moves yo ‘Neutral’ Zone
12.10.2026 02:42
CNN Fear & Greed Index rose to Neutral at 45 as U.S. stocks gained Friday; Dow jumped 423 points, while consumer sentiment weakened.
Humana's Star Ratings Progress Doesn't Erase Valuation Concerns
11.10.2026 10:00
Humana stock: efficiency gains and better Star Ratings, but margins/cash flow pressured. Click for more on HUM stock.
Humana (HUM) Deepens MA Neuromodulation Coverage: A Clue to Its Margin Recovery Strategy?
10.10.2026 00:14
In early October 2026, BlueWind Medical announced that Humana began covering implantable tibial neuromodulation therapy for urgency urinary incontinence, including BlueWind’s Revi System, across its Medicare Advantage membership of about 11 million enrollees. This coverage decision, backed by multi‑year OASIS clinical data and a new AMA Category I CPT code for subfascial tibial neuromodulation, highlights how Humana may be broadening access to advanced, home‑managed therapies for seniors...